Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

734 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Program for the epidemiological evaluation of stroke in Tandil, Argentina (PREVISTA) study: rationale and design.
Sposato LA, Coppola ML, Altamirano J, Borrego Guerrero B, Casanova J, De Martino M, Díaz A, Feigin VL, Funaro F, Gradillone ME, Lewin ML, Lopes RD, López DH, Louge M, Maccarone P, Martens C, Miguel M, Rabinstein A, Morasso H, Riccio PM, Saposnik G, Silva D, Suasnabar R, Truelsen T, Uzcudun A, Viviani CA, Bahit MC. Sposato LA, et al. Among authors: lopes rd. Int J Stroke. 2013 Oct;8(7):591-7. doi: 10.1111/ijs.12171. Int J Stroke. 2013. PMID: 24024917
Efficacy and safety of apixaban compared with warfarin for stroke prevention in patients with atrial fibrillation from East Asia: a subanalysis of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial.
Goto S, Zhu J, Liu L, Oh BH, Wojdyla DM, Aylward P, Bahit MC, Gersh BJ, Hanna M, Horowitz J, Lopes RD, Wallentin L, Xavier D, Alexander JH; ARISTOTLE Investigators. Goto S, et al. Among authors: lopes rd. Am Heart J. 2014 Sep;168(3):303-9. doi: 10.1016/j.ahj.2014.06.005. Epub 2014 Jun 6. Am Heart J. 2014. PMID: 25173541 Clinical Trial.
Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
Granger CB, Lopes RD, Hanna M, Ansell J, Hylek EM, Alexander JH, Thomas L, Wang J, Bahit MC, Verheugt F, Lawrence J, Xavier D, Wallentin L. Granger CB, et al. Among authors: lopes rd. Am Heart J. 2015 Jan;169(1):25-30. doi: 10.1016/j.ahj.2014.09.006. Epub 2014 Sep 28. Am Heart J. 2015. PMID: 25497244
Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial.
Avezum A, Lopes RD, Schulte PJ, Lanas F, Gersh BJ, Hanna M, Pais P, Erol C, Diaz R, Bahit MC, Bartunek J, De Caterina R, Goto S, Ruzyllo W, Zhu J, Granger CB, Alexander JH. Avezum A, et al. Among authors: lopes rd. Circulation. 2015 Aug 25;132(8):624-32. doi: 10.1161/CIRCULATIONAHA.114.014807. Epub 2015 Jun 23. Circulation. 2015. PMID: 26106009 Clinical Trial.
Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trial.
Vinereanu D, Stevens SR, Alexander JH, Al-Khatib SM, Avezum A, Bahit MC, Granger CB, Lopes RD, Halvorsen S, Hanna M, Husted S, Hylek EM, Mărgulescu AD, Wallentin L, Atar D. Vinereanu D, et al. Among authors: lopes rd. Eur Heart J. 2015 Dec 7;36(46):3268-75. doi: 10.1093/eurheartj/ehv447. Epub 2015 Sep 14. Eur Heart J. 2015. PMID: 26371113 Clinical Trial.
Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial.
Rao MP, Halvorsen S, Wojdyla D, Thomas L, Alexander JH, Hylek EM, Hanna M, Bahit MC, Lopes RD, De Caterina R, Erol C, Goto S, Lanas F, Lewis BS, Husted S, Gersh BJ, Wallentin L, Granger CB; Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Steering Committee and Investigators. Rao MP, et al. Among authors: lopes rd. J Am Heart Assoc. 2015 Dec 1;4(12):e002015. doi: 10.1161/JAHA.115.002015. J Am Heart Assoc. 2015. PMID: 26627878 Free PMC article. Clinical Trial.
History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial.
De Caterina R, Andersson U, Alexander JH, Al-Khatib SM, Bahit MC, Goto S, Hanna M, Held C, Hohnloser S, Hylek EM, Lanas F, Lopes RD, López-Sendón J, Renda G, Horowitz J, Granger CB, Wallentin L; ARISTOTLE Investigators. De Caterina R, et al. Among authors: lopes rd. Am Heart J. 2016 May;175:175-83. doi: 10.1016/j.ahj.2016.01.005. Epub 2016 Jan 19. Am Heart J. 2016. PMID: 27179738 Free article. Clinical Trial.
First-Ever Stroke and Transient Ischemic Attack Incidence and 30-Day Case-Fatality Rates in a Population-Based Study in Argentina.
Bahit MC, Coppola ML, Riccio PM, Cipriano LE, Roth GA, Lopes RD, Feigin VL, Borrego Guerrero B, De Martino M, Díaz A, Ferrante D, Funaro F, Lavados P, Lewin ML, López DH, Macarrone P, Marciello R, Marino D, Martens C, Martínez P, Odriozola G, Rabinstein AA, Saposnik G, Silva D, Suasnabar R, Truelsen T, Uzcudun A, Viviani CA, Sposato LA. Bahit MC, et al. Among authors: lopes rd. Stroke. 2016 Jun;47(6):1640-2. doi: 10.1161/STROKEAHA.116.013637. Epub 2016 May 5. Stroke. 2016. PMID: 27217510
Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation.
Bahit MC, Lopes RD, Wojdyla DM, Held C, Hanna M, Vinereanu D, Hylek EM, Verheugt F, Goto S, Alexander JH, Wallentin L, Granger CB. Bahit MC, et al. Among authors: lopes rd. Heart. 2017 Apr;103(8):623-628. doi: 10.1136/heartjnl-2016-309901. Epub 2016 Oct 24. Heart. 2017. PMID: 27798052 Free PMC article. Clinical Trial.
734 results